407 related articles for article (PubMed ID: 27173008)
1. Oral tranexamic acid lightens refractory melasma.
Tan AWM; Sen P; Chua SH; Goh BK
Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008
[TBL] [Abstract][Full Text] [Related]
2. Oral tranexamic acid for the treatment of melasma.
Karn D; Kc S; Amatya A; Razouria EA; Timalsina M
Kathmandu Univ Med J (KUMJ); 2012; 10(40):40-3. PubMed ID: 23575051
[TBL] [Abstract][Full Text] [Related]
3. Combination of Oral Tranexamic Acid with Topical 3% Tranexamic Acid versus Oral Tranexamic Acid with Topical 20% Azelaic Acid in the Treatment of Melasma.
Malik F; Hanif MM; Mustafa G
J Coll Physicians Surg Pak; 2019 Jun; 29(6):502-504. PubMed ID: 31133144
[TBL] [Abstract][Full Text] [Related]
4. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of oral tranexemic acid in refractory melasma: A clinico-immuno-histopathological study.
Nagaraju D; Bhattacharjee R; Vinay K; Saikia UN; Parsad D; Kumaran MS
Dermatol Ther; 2018 Sep; 31(5):e12704. PubMed ID: 30253023
[TBL] [Abstract][Full Text] [Related]
6. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
[TBL] [Abstract][Full Text] [Related]
7. Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser.
Cho HH; Choi M; Cho S; Lee JH
J Dermatolog Treat; 2013 Aug; 24(4):292-6. PubMed ID: 22103770
[TBL] [Abstract][Full Text] [Related]
8. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial.
Kanechorn Na Ayuthaya P; Niumphradit N; Manosroi A; Nakakes A
J Cosmet Laser Ther; 2012 Jun; 14(3):150-4. PubMed ID: 22506692
[TBL] [Abstract][Full Text] [Related]
9. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial.
Lee JH; Park JG; Lim SH; Kim JY; Ahn KY; Kim MY; Park YM
Dermatol Surg; 2006 May; 32(5):626-31. PubMed ID: 16706756
[TBL] [Abstract][Full Text] [Related]
10. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of topical versus intradermal injection of Tranexamic Acid In Egyptian melasma Patients: A randomised clinical trial.
Badran AY; Ali AU; Gomaa AS
Australas J Dermatol; 2021 Aug; 62(3):e373-e379. PubMed ID: 33782959
[TBL] [Abstract][Full Text] [Related]
12. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
Del Rosario E; Florez-Pollack S; Zapata L; Hernandez K; Tovar-Garza A; Rodrigues M; Hynan LS; Pandya AG
J Am Acad Dermatol; 2018 Feb; 78(2):363-369. PubMed ID: 28987494
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid as a therapeutic option for melasma management: meta-analysis and systematic review of randomized controlled trials.
Calacattawi R; Alshahrani M; Aleid M; Aleid F; Basamih K; Alsugair G; Alqahtani R; AlKhabbaz N; Algaidi Y; Alrakayan L; Almohanna A; Madkhali A; Aljohani S; Alotibi N
J Dermatolog Treat; 2024 Dec; 35(1):2361106. PubMed ID: 38843906
[No Abstract] [Full Text] [Related]
14. Efficacy and possible mechanisms of topical tranexamic acid in melasma.
Kim SJ; Park JY; Shibata T; Fujiwara R; Kang HY
Clin Exp Dermatol; 2016 Jul; 41(5):480-5. PubMed ID: 27135282
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review.
Kim HJ; Moon SH; Cho SH; Lee JD; Kim HS
Acta Derm Venereol; 2017 Jul; 97(7):776-781. PubMed ID: 28374042
[TBL] [Abstract][Full Text] [Related]
17. A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma.
Khurana VK; Misri RR; Agarwal S; Thole AV; Kumar S; Anand T
Indian J Dermatol Venereol Leprol; 2019; 85(1):39-43. PubMed ID: 30333359
[TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies.
Taraz M; Niknam S; Ehsani AH
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133910
[TBL] [Abstract][Full Text] [Related]
19. Oral tranexamic acid for the treatment of melasma.
Ali FR
Clin Exp Dermatol; 2019 Apr; 44(3):347-349. PubMed ID: 30484898
[No Abstract] [Full Text] [Related]
20. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
Basit A; Rahman A; Uddin R
J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
